Explainability Audit Reveals Insights into Drug-Target Interaction Prediction Models.

Ali Vefghi, Zahed Rahmati, Mohammad Akbari· June 15, 2026 View original

Summary

A study presents an interpretability audit of the BridgeDPI architecture, combining various gradient-based attribution methods with occlusion ablation. The research reveals how black-box drug-target interaction (DTI) and affinity (DTA) prediction models utilize features, offering insights into modality dominance and dataset-dependent effects.

Drug-target interaction (DTI) and affinity (DTA) prediction models are achieving high performance, but their internal workings, especially regarding sequence, fingerprint, and graph features, often remain unclear. This research conducts an interpretability audit on the BridgeDPI architecture across multiple datasets. The study employs a combination of gradient-based attribution methods, such as integrated gradients and SmoothGrad, alongside feature-wise occlusion ablation. By using a strict intersection consensus across these methods, the aim is to mitigate biases from single explainers and provide a more robust understanding of model behavior. The findings indicate that explainability serves as valuable model criticism, uncovering issues like modality dominance, artifacts from padding, and chemistry-consistent fragment motifs. While not a substitute for experimental validation, these analyses can generate testable hypotheses for computational drug discovery and highlight the potential of XAI in understanding complex DTI/DTA models.

Why it matters

For professionals in drug discovery and AI development, understanding how DTI/DTA models make predictions is crucial for building trust, identifying biases, and generating experimentally verifiable hypotheses, accelerating drug development.

How to implement this in your domain

  1. 1Apply cross-method explainability techniques to your black-box AI models in drug discovery.
  2. 2Utilize interpretability audits to identify modality dominance and feature importance in DTI/DTA predictions.
  3. 3Generate testable hypotheses from XAI insights for downstream experimental validation.
  4. 4Critically evaluate model outputs by understanding which input features drive specific predictions.

Who benefits

PharmaceuticalsBiotechnologyHealthcareScientific Research

Key takeaways

  • Cross-method explainability enhances understanding of black-box DTI/DTA prediction models.
  • Interpretability audits reveal modality dominance and dataset-specific effects in AI models.
  • XAI can generate testable hypotheses for experimental validation in drug discovery.
  • Understanding model internals is crucial for trust and bias identification in critical applications.

Original post by Ali Vefghi, Zahed Rahmati, Mohammad Akbari

"arXiv:2606.14245v1 Announce Type: new Abstract: Drug-target interaction (DTI) and affinity (DTA) predictors increasingly achieve strong benchmark scores, yet their internal use of sequence, fingerprint, and graph features often remains opaque. We present an interpretability audit…"

View on X

Originally posted by Ali Vefghi, Zahed Rahmati, Mohammad Akbari on X · view source

Want to go deeper?

Turn these trends into skills with Learnijoy's hands-on AI & tech courses.

Explore courses